Safety is the paramount concern in the US blood plasma derivatives industry, governed by the strict oversight of the Food and Drug Administration (FDA). The US has pioneered many of the "Multiple-Gate" safety protocols used today, including nucleic acid testing (NAT) and advanced viral inactivation steps such as solvent-detergent treatment and nanofiltration. These rigorous standards ensure...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek